Position in STRO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,206,562
+$3,811,707 QoQ
Shares Held
458,029
+0.1% QoQ
Ownership
2.76%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#12
of 97 holders
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. STRO ranks #75 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in STRO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,206,562 | 458,029 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,394,855 | 457,441 | Shares | Sole | 2026-05-15 | |
| 2022-09-30 | $410,444 | 73,954 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $385,300 | 73,954 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $318,738 | 38,776 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $4,146,562 | 219,511 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,080,709 | 219,511 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,915,568 | 215,974 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,955,106 | 182,179 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||